Clinical Trial Update: Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 trial of a biologic therapy for refractory primary non-ANCA associated vasculitis; the study was terminated and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiitis of the Central Nervous System
• Cogan Syndrome
• Cryoglobulinemic Vasculitis
• Giant Cell Arteritis
• Iga Vasculitis
• Polyarteritis Nodosa
• Relapsing Polychondritis
• Takayasu Arteritis

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Giant Cell Arteritis, Takayasu Arteritis | Phase 2 | Status: TERMINATED | Results posted: 2025-06-17